Navigation Links
MedClean Technologies, Inc. Announces $1 Million Order
Date:2/18/2009

Enables Solution Provider on Major Caribbean Basin Island To Provide Healthcare Industry a Regulated Medical Waste Alternative to Stericycle Plus Confidential Document Destruction Services

BETHEL, Conn., Feb. 18 /PRNewswire-FirstCall/ -- MedClean Technologies, Inc. (OTC Bulletin Board: MCLN), a provider of innovative technology and services for onsite treatment and disposal of regulated medical waste (RMW), today announced it has finalized a contract valued at approximately $1 million to provide a turnkey system to a RMW processing provider on a major island in the Caribbean Basin.

This MedClean system includes dual sterilization units, capable of treating 3 million pounds of RMW annually, as well as a high performance, volume reduction shredder. This system will enable the customer to launch a service line providing an economic RMW treatment and processing alternative to Stericycle for the island's healthcare industry. This customer will gain the added capability to effectively address confidential document destruction on the island.

"In addition to validating our ability to address the turnkey hauler facility segment as targeted in MedClean's strategic business plan, this contract is significant for several reasons," said Scott Grisanti, President and Chief Executive Officer of MedClean. "It demonstrates scalability and configurability of the standard technology platform shared by our on-demand containerized solutions. Further, it illustrates our ability to extend our reach beyond the continental U.S. and leverage the MedClean agent network, which was critical to this transaction. Finally, the technical and business collaboration at our company that was required to complete this deal exemplifies our new leadership's thorough and disciplined approach to ensure success for all of our stakeholders. The same cooperative effort that allowed MedClean to develop the patent-pending technology for our on-demand containers was of paramount importance to our ability to design a solution for this complex application."

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean(R) Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at http://www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at http://www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2007, filed with the SEC on March 31, 2008, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

    Contacts:
    MedClean Technologies, Inc.               Investor Contact:
    Kevin Dunphy                              Cameron Donahue
    Chief Financial Officer                   Hayden IR
    (203) 798-1080                            (651) 653-1854
    kdunphy@medcleantechnologies.com          cameron@haydenir.com


'/>"/>
SOURCE MedClean Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedClean Technologies Inc. Announces New Ticker Symbol
2. MedClean Technologies Inc. CEO Publishes Letter to Shareholders
3. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
4. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
5. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
6. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
7. ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products
8. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
9. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
10. ReBuilder Medical Technologies, Inc. Announces Agreement with Internet Marketer Helio Health; Anticipates 12% Additional Profit
11. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: